PURPLE BIOTECH LTD.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $10.4M | $4.4M |
| FY2020 | — | $79.4M | $11.2M |
| FY2021 | — | $64.8M | $10.9M |
| FY2022 | — | $46.9M | $15.0M |
| FY2023 | — | $34.2M | $14.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $10.4M | $4.4M |
| FY2020 | — | $79.4M | $11.2M |
| FY2021 | — | $64.8M | $10.9M |
| FY2022 | — | $46.9M | $15.0M |
| FY2023 | — | $34.2M | $14.5M |